PharmaVOICE Podcasts

In this episode, Mr. Domann discusses a retail strategy for minimizing prescription abandonment for brands at many stages in the product lifecycle. We cover how pharmacies and pharmacists play integral roles in the strategy. Thought Leader: Dick Domann, Vice President, Pharmacy Services, TrialCard Inc. Play podcast

In this episode, Patricia Ensor discusses the characteristics and behaviors of the uninsured, how they relate to the Affordable Care Act (ACA), and what it means for Pharma. Thought Leader: Patricia Ensor, RPh, Senior Advisor, Kantar Health Play podcast

The market of biologics is growing at a nearly twice the rate of pharma as a whole. Biobetters are the next big opportunity for biopharma to benefit from this growth. This podcast will explore the regulatory and scientific considerations for the development of biobetters. Thought Leader: Hazel Gorham, Ph.D., Director, Biosimilars Development, PRA Play podcast

In this episode, Ms. Ruby discusses how clinical trials are like skydiving, what some of the key challenges are in clinical trials, solving unexpected challenges, and creating a productive and collaborative relationship between CROs and sponsors. Thought Leader: Barbara Ruby, Project Director, SynteractHCR, Inc. Play podcast

In this episode, Mr. Penniston and Ms. Taber talk about risk-based monitoring what it is, why it's important, what are the components, what skill sets or tools are necessary, and the challenges and opportunities related to risk-based monitoring. Thought Leaders: Mark Penniston, Senior Vice President and General Manager, Clinical Analytics, Theorem Clinical Research and Alison Taber, Vice President of Global Data Management, Theorem Clinical Research Play podcast

In this episode, Mr. Lammers talks about using a multichannel business strategy in life science companies. He defines the multichannel approach, covers the core challenges, offers his review on Pharma's adoption of multichannel, and provides advice for commercial leaders. Thought Leader: Peter Lammers, VP, Strategy, Veeva Systems Play podcast

In this episode, Mr. Dockery covers several issues related to patient adherence, including using Big Data to predict patient behavior and improve adherence in a patient population, as well as how to accurately measure adherence rates. Thought Leader: Jim Dockery, Executive Director, Market Data Insights and Innovation, Adheris Play podcast

In this episode, we discuss the challenges in pharma regarding workforce management, the growing trend of strategic workforce planning, and how this phenomenon will continue to evolve over the next 5 years. Thought Leader: Mark Lanfear, Global Practice Leader, Americas Scientific Product Group, Kelly Services, Inc. Play podcast

In this episode, Craig Flanagan and DJ Mitsch talk about a major culture change at Sanofi Pharmaceuticals North America: how they designed it, implemented it, what the results were, and the future of this significant undertaking. This podcast will be of great interest to anyone at a large company who is considering or has decided to implement a powerful culture change. Thought Leaders: Darelyn "DJ" Mitsch, President, The Pyramid Resource Group, Inc. and Craig Flanagan, VP, Business Excellence and Commercial Capabilities, sanofi-aventis Play podcast

In this episode, Dr. Davis discusses open innovation, nontraditional partnerships, collaboration, new technologies, and the future of R&D. Thought Leader: Dr. Hugh Davis, VP and head of Biologics Clinical Pharmacology Biotechnology Center of Excellence, Janssen Research and Development Play podcast